Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fraia Melchionda

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Cell Cycle (Georgetown, Tex.)|June 21, 2012
Activity of the selective IκB kinase inhibitor BMS-345541 against T-cell acute lymphoblastic leukemia: involvement of FOXO3aFrancesca Buontempo, Francesca Chiarini, Daniela Bressanin, et al.
Pediatric Blood & Cancer|August 7, 2019
Prognostic role of pleural effusion or ascites in localized rhabdomyosarcomaDaniela Di Carlo, Andrea Ferrari, Tiziana Toffolutti, et al.
Healthcare (Basel, Switzerland)|January 11, 2024
A 10-Year Retrospective Study on Pediatric Visceral Leishmaniasis in a European Endemic Area: Diagnostic and Short-Course Therapeutic StrategiesArianna Dondi, Elisa Manieri, Giacomo Gambuti, et al.
Pediatric Blood & Cancer|August 30, 2020
Defining the impact of prognostic factors at the time of relapse for nonmetastatic rhabdomyosarcomaMaria Carmen Affinita, Andrea Ferrari, Stefano Chiaravalli, et al.
Oncotarget|October 31, 2015
Whole transcriptome sequencing identifies BCOR internal tandem duplication as a common feature of clear cell sarcoma of the kidneyAnnalisa Astolfi, Fraia Melchionda, Daniela Perotti, et al.
Oncotarget|August 14, 2012
Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: eliminating activity by targeting at different levelsDaniela Bressanin, Camilla Evangelisti, Francesca Ricci, et al.
Journal of Clinical Microbiology|February 13, 2026
Analytical and clinical performance of in-house and commercial real-time PCR assays for diagnosing <i>L. infantum</i> visceral leishmaniasis: a study from a hub center in Northern ItalyTommaso Gritti, Beatrice Mola, Lisa Argnani, et al.
British Journal of Haematology|May 11, 2012
A prospective, randomized study of empirical antifungal therapy for the treatment of chemotherapy-induced febrile neutropenia in childrenDésirée Caselli, Simone Cesaro, Ottavio Ziino, et al.
Cancer Research|September 30, 2010
Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 against T-cell acute lymphoblastic leukemiaFrancesca Chiarini, Cecilia Grimaldi, Francesca Ricci, et al.
Frontiers in Genetics|December 9, 2022
Mutational analysis of ribosomal proteins in a cohort of pediatric patients with T-cell acute lymphoblastic leukemia reveals Q123R, a novel mutation in RPL10Lorenza Bacci, Valentina Indio, Guglielmo Rambaldelli, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Cell Cycle (Georgetown, Tex.)|June 21, 2012
Activity of the selective IκB kinase inhibitor BMS-345541 against T-cell acute lymphoblastic leukemia: involvement of FOXO3aFrancesca Buontempo, Francesca Chiarini, Daniela Bressanin, et al.
Pediatric Blood & Cancer|August 7, 2019
Prognostic role of pleural effusion or ascites in localized rhabdomyosarcomaDaniela Di Carlo, Andrea Ferrari, Tiziana Toffolutti, et al.
Healthcare (Basel, Switzerland)|January 11, 2024
A 10-Year Retrospective Study on Pediatric Visceral Leishmaniasis in a European Endemic Area: Diagnostic and Short-Course Therapeutic StrategiesArianna Dondi, Elisa Manieri, Giacomo Gambuti, et al.
Pediatric Blood & Cancer|August 30, 2020
Defining the impact of prognostic factors at the time of relapse for nonmetastatic rhabdomyosarcomaMaria Carmen Affinita, Andrea Ferrari, Stefano Chiaravalli, et al.
Oncotarget|October 31, 2015
Whole transcriptome sequencing identifies BCOR internal tandem duplication as a common feature of clear cell sarcoma of the kidneyAnnalisa Astolfi, Fraia Melchionda, Daniela Perotti, et al.
Oncotarget|August 14, 2012
Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: eliminating activity by targeting at different levelsDaniela Bressanin, Camilla Evangelisti, Francesca Ricci, et al.
Journal of Clinical Microbiology|February 13, 2026
Analytical and clinical performance of in-house and commercial real-time PCR assays for diagnosing <i>L. infantum</i> visceral leishmaniasis: a study from a hub center in Northern ItalyTommaso Gritti, Beatrice Mola, Lisa Argnani, et al.
British Journal of Haematology|May 11, 2012
A prospective, randomized study of empirical antifungal therapy for the treatment of chemotherapy-induced febrile neutropenia in childrenDésirée Caselli, Simone Cesaro, Ottavio Ziino, et al.
Cancer Research|September 30, 2010
Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 against T-cell acute lymphoblastic leukemiaFrancesca Chiarini, Cecilia Grimaldi, Francesca Ricci, et al.
Frontiers in Genetics|December 9, 2022
Mutational analysis of ribosomal proteins in a cohort of pediatric patients with T-cell acute lymphoblastic leukemia reveals Q123R, a novel mutation in RPL10Lorenza Bacci, Valentina Indio, Guglielmo Rambaldelli, et al.
Pageof 5